Lv712
3338 积分 2022-03-03 加入
Combined SHP2 and KRASG12C inhibitor therapy in patients with non-small-cell lung cancer
1天前
求助中
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
1天前
已完结
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
1天前
已完结
Hepatitis B A Review
1天前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
3天前
已完结
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
3天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
5天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
5天前
已完结
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung
10天前
已完结
Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
13天前
已关闭
皖公网安备34019202002308
